Location · Rochester, MN
Clinical trials in Rochester, MN
271 recruiting studies have a site in Rochester, and 115 of them accept healthy volunteers.
271 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
GlaxoSmithKline
- Location
- Rochester, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
- Location
- Rochester, MN + 73 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
Health Discovery Labs
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
BioPoly® Partial Resurfacing Knee Implant IDE
BioPoly LLC
- Location
- Rochester, MN + 3 other US sites
- Eligibility basics
- Ages 30–65
- Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Medtronic Cardiovascular
- Location
- Rochester, MN + 27 other US sites
- Eligibility basics
- Ages 20+
- RecruitingPhase 3
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
Agitated Solutions, Inc.
- Location
- Rochester, MN + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Rochester, MN + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1/Phase 2
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Alexion Pharmaceuticals, Inc.
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
GE Healthcare
- Location
- Rochester, MN + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Rochester, MN + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ansun Biopharma, Inc.
- Location
- Rochester, MN + 18 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Sanofi
- Location
- Rochester, MN + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingEarly Phase 1
VTP-1000 in Adults With Celiac Disease
Barinthus Biotherapeutics
- Location
- Rochester, MN + 15 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Alexion Pharmaceuticals, Inc.
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
ONWARD Medical, Inc.
- Location
- Rochester, MN + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Rise Therapeutics LLC
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Rochester, MN + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
Exegi Pharma, LLC
- Location
- Rochester, MN + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc.
- Location
- Rochester, MN + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Takeda
- Location
- Rochester, MN + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
AbbVie
- Location
- Rochester, MN + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type II
AUG Therapeutics
- Location
- Rochester, MN
- Eligibility basics
- Ages 6 mo–75
- RecruitingPhase 3
An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II
AUG Therapeutics
- Location
- Rochester, MN
- Eligibility basics
- Ages 6 mo–75
- RecruitingPhase 2
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Singulera Therapeutics Inc.
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18–65